| Metric | FY2021 | FY2020 |
|---|---|---|
| Research and development | $20.3M+36.5% | $14.9M |
| General and administrative | $10.9M-15.3% | $12.9M |
| In-process R&D | $50.6M | $0 |
| Total operating expenses | $81.9M+194.4% | $27.8M |
| Loss from operations | -$81.9M-194.4% | -$27.8M |
| Other expense | -$299K+81.9% | -$1.7M |
| Loss before income tax expense | -$82.2M-178.9% | -$29.5M |
| Income tax expense | $0+100.0% | -$32K |
| Net loss | -$82.2M-178.6% | -$29.5M |
| Net loss per share - basic and diluted | -$1.31-36.5% | -$0.96 |
| Basic and diluted weighted average shares outstanding | 62.9M+104.3% | 30.8M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.